Analysis of von willebrand factor A domain-related protein (WARP) polymorphism in temperate and tropical Plasmodium vivax field isolates

Malaria Journal

Volumn 8, Issue 1, 2009, Pages

  Gholizadeh, Saber ^a,b   Djadid, Navid Dinparast ^a   Basseri, Hamid Reza ^c   Zakeri, Sedigheh ^a   Ladoni, Hossein ^c  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b Tehran University of Medical Sciences ^*  (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR A DOMAIN RELATED PROTEIN; PRIMER DNA; PROTOZOAL PROTEIN; WARP PROTEIN, PLASMODIUM;

AMINO ACID SUBSTITUTION; ARTICLE; BIOINFORMATICS; GENE; GENE AMPLIFICATION; GENE SEQUENCE; IRAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN POLYMORPHISM; SEQUENCE ANALYSIS; AMINO ACID SEQUENCE; ANIMAL; CLIMATE; DISEASE TRANSMISSION; GENETIC POLYMORPHISM; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; PHYLOGENY;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CLIMATE; DNA PRIMERS; HUMANS; IRAN; MALARIA, VIVAX; MOLECULAR SEQUENCE DATA; PHYLOGENY; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS;

EID: 68249138915     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-8-137     Document Type: Article

References (40)

1. Neglect of Plasmodium vivax malaria. JK Baird, Trends Parasitol 2007 23 533 539 10.1016/j.pt.2007.08.011 17933585 (Pubitemid 350026468)
2. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. E Tjitra NM Anstey P Sugiarto N Warikar E Kenangalem M Karyana DA Lampah RN Price, PLoS Medicine 2008 5 e128 18563962 10.1371/journal.pmed.0050128 (Pubitemid 351919110)
3. Atypical manifestations of Plasmodium vivax malaria. MK Mohapatra KN Padhiary DP Mishra G Sethy, Indian J Malariol 2002 39 18 25 14686106
4. Plasmodium vivax malaria. DK Kochar V Saxena N Singh SK Kochar SV Kumar A Das, Emerg Infect Dis 2005 11 132 134 15705338
5. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. B Genton V D'Acremont L Rare K Baea JC Reeder MP Alpers I Muller, PLoS Med 2008 5 e127 18563961 10.1371/journal.pmed.0050127 (Pubitemid 351919109)
6. Transmission blocking malaria vaccines. R Carter, Vaccine 2001 19 2309 2314 10.1016/S0264-410X(00)00521-1 11257353 (Pubitemid 32234233)
7. Transmission-blocking vaccines: uses and current status of development. DC Kaslow, Int J Parasitol 1997 27 183 189 10.1016/S0020-7519(96)00148-8 9088989 (Pubitemid 27139709)
8. Current developments in malaria transmission-blocking vaccines. A Stowers R Carter, Expert Opinion on Biological Therapy 2001 1 619 628 10.1517/14712598.1.4.619 11727498
9. Fitness of anopheline mosquitoes expressing transgenes that inhibit Plasmodium development. LA Moreira J Wang FH Collins M Jacobs-Lorena, Genetics 2004 166 1337 1341 15082552 10.1534/genetics.166.3.1337 (Pubitemid 38507052)
10. Pfs230: from malaria transmission-blocking vaccine candidate toward function. KC Williamson, Parasite Immunol 2003 25 351 359 10.1046/j.1365-3024. 2003.00643.x 14521577 (Pubitemid 38019278)
11. A central role for P48/45 in malaria parasite male gamete fertility. MR van Dijk CJ Janse J Thompson AP Waters JA Braks HJ Dodemont HG Stunnenberg GJ van Gemert RW Sauerwein W Eling, Cell 2001 104 153 164 10.1016/S0092-8674(01) 00199-4 11163248 (Pubitemid 32144980)
12. P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions. AM Tomas G Margos G Dimopoulos LH van Lin TF de Koning-Ward R Sinha P Lupetti AL Beetsma MC Rodriguez M Karras, Embo J 2001 20 3975 3983 11483501 10.1093/emboj/20.15.3975 (Pubitemid 32751814)
13. Transmission-blocking vaccine of vivax malaria. T Tsuboi M Tachibana O Kaneko M Torii, Parasitol Int 2003 52 1 11 10.1016/S1383-5769(02)00037-5 12543142 (Pubitemid 36110516)
14. Analysis of the Plasmodium and Anopheles transcriptional repertoire during ookinete development and midgut invasion. EG Abraham S Islam P Srinivasan AK Ghosh JG Valenzuela JM Ribeiro FC Kafatos G Dimopoulos M Jacobs-Lorena, J Biol Chem 2004 279 5573 5580 10.1074/jbc.M307582200 14627712 (Pubitemid 38220583)
15. von Willebrand Factor A domain-related protein, a novel microneme protein of the malaria ookinete highly conserved throughout Plasmodium parasites. M Yuda K Yano T Tsuboi M Torii Y Chinzei, Mol Biochem Parasitol 2001 116 65 72 10.1016/S0166-6851(01)00304-8 11463467 (Pubitemid 32706427)
16. Circumsporozoite protein gene diversity among temperate and tropical Plasmodium vivax isolates from Iran. S Zakeri A Abouie Mehrizi ND Djadid G Snounou, Trop Med Int Health 2006 11 729 737 10.1111/j.1365-3156.2006.01613.x 16640626
17. Population structure analysis of Plasmodium vivax in areas of Iran with different malaria endemicity. S Zakeri AA Mehrizi S Mamaghani S Noorizadeh G Snounou ND Djadid, Am J Trop Med Hyg 2006 74 394 400 16525096
18. Genetic diversity of transmission blocking vaccine candidate (Pvs25 and Pvs28) antigen in Plasmodium vivax clinical isolates from Iran. S Zakeri S Razavi D ND, Acta Trop 2009 109 176 80 10.1016/j.actatropica.2008.09.012 18950597
19. Plasmodium ookinete-secreted proteins secreted through a common micronemal pathway are targets of blocking malaria transmission. F Li TJ Templeton V Popov JE Comer T Tsuboi M Torii JM Vinetz, J Biol Chem 2004 279 26635 26644 10.1074/jbc.M401385200 15069061 (Pubitemid 38798821)
20. Molecular evidence of mixed P. vivax and P. falciparum infections in northern Islamic Republic of Iran. S Zakeri S Mamaghani AA Mehrizi Z Shahsavari A Raeisi S Arshi N Dinparast-Djadid, East Mediterr Health J 2004 10 336 342 16212210
21. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. G Snounou S Viriyakosol W Jarra S Thaithong KN Brown, Mol Biochem Parasitol 1993 58 283 292 10.1016/0166-6851(93)90050-8 8479452
22. BLAST. http://www.ncbi.nlm.nih.gov/blast/
23. PlasmoDB. http://www.plasmodb.org
24. MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0. K Tamura J Dudley M Nei S Kumar, Mol Biol Evol 2007 24 1596 1599 10.1093/molbev/msm092 17488738 (Pubitemid 47236692)
25. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. J Thompson D Higgins T Gibson, Nucleic Acids Res 1994 22 4673 4680 7984417 10.1093/nar/22.22.4673
26. IEDB Analysis Resource. http://tools.immuneepitope.org
27. The design of Jemboss: a graphical user interface to EMBOSS. T Carver A Bleasby, Bioinformatics 2003 19 1837 1843 10.1093/bioinformatics/btg251 14512356 (Pubitemid 37220476)
28. A neural network method for identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. H Nielsen J Engelbrecht S Brunak G von Heijine, Int J Neural Syst 1997 8 581 599 10.1142/ S0129065797000537 10065837
29. Mosquito stage, transmission blocking vaccines for malaria. A Saul, Curr Opin Infect Dis 2007 20 476 481 10.1097/QCO.0b013e3282a95e12 17762780 (Pubitemid 47359643)
30. Characterization of antigens on mosquito midgut stages of Plasmodium gallinaceum. II. Comparison of surface antigens of male and female gametes and zygotes. DC Kaushal R Carter, Mol Biochem Parasitol 1984 11 145 156 10.1016/0166-6851(84)90061-6 6146930 (Pubitemid 14082585)
31. Identification of novel Plasmodium gallinaceum zygote- and ookinete-expressed proteins as targets for blocking malaria transmission. RC Langer F Li JM Vinetz, Infect Immun 2002 70 102 106 11748169 10.1128/IAI.70.1.102-106.2002 (Pubitemid 34028604)
32. An anti-Chitinase malaria transmission-blocking single-chain antibody as an effector molecule for creating a Plasmodium falciparum-refractory mosquito. F Li KP Patra JM Vinetz, J Infect Dis 2005 192 878 887 16088838 10.1086/432552 (Pubitemid 41193086)
33. Targeted disruption of the Plasmodium berghei CTRP gene reveals its essential role in malaria infection of the vector mosquito. M Yuda H Sakaida Y Chinzei, J Exp Med 1999 190 1711 1716 10587361 10.1084/jem.190.11.1711 (Pubitemid 30002352)
34. CTRP is essential for mosquito infection by malaria ookinetes. JT Dessens AL Beetsma G Dimopoulos K Wengelnik A Crisanti FC Kafatos RE Sinden, Embo J 1999 18 6221 6227 10562534 10.1093/emboj/18.22.6221 (Pubitemid 29533226)
35. Close association of invading Plasmodium berghei and beta integrin in the Anopheles gambiae midgut. V Mahairaki G Lycett I Siden-Kiamos RE Sinden C Louis, Arch Insect Biochem Physiol 2005 60 13 19 10.1002/arch.20077 16116619 (Pubitemid 41625815)
36. SOAP, a novel malaria ookinete protein involved in mosquito midgut invasion and oocyst development. JT Dessens I Siden-Kiamos J Mendoza V Mahairaki E Khater D Vlachou XJ Xu FC Kafatos C Louis G Dimopoulos, Mol Microbiol 2003 49 319 329 10.1046/j.1365-2958.2003.03566.x 12828632 (Pubitemid 36851190)
37. Essential role of membrane-attack protein in malarial transmission to mosquito host. K Kadota T Ishino T Matsuyama Y Chinzei M Yuda, Proc Natl Acad Sci USA 2004 101 16310 16315 15520375 10.1073/pnas.0406187101 (Pubitemid 39552841)
38. A proteomic view of the Plasmodium falciparum life cycle. L Florens MP Washburn JD Raine RM Anthony M Grainger JD Haynes JK Moch N Muster JB Sacci DL Tabb, Nature 2002 419 520 526 10.1038/nature01107 12368866
39. PSLAP, a protein with multiple adhesive motifs, is expressed in Plasmodium falciparum gametocytes. I Delrieu CC Waller MM Mota M Grainger J Langhorne AA Holder, Mol Biochem Parasitol 2002 121 11 20 10.1016/S0166-6851(02) 00016-6 11985859 (Pubitemid 34457830)
40. Limited polymorphism in Plasmodium falciparum ookinete surface antigen, von Willebrand factor A domain-related protein from clinical isolates. JS Richards NJ MacDonald DP Eisen, Malar J 2006 5 55 16820064 10.1186/1475-2875-5- 55 (Pubitemid 44195486)